EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Donor Heart Allocation Systems in Europe A Scientific Statement of the Heart Failure Association of the ESC

Hoong Sern Lim, Kevin Damman, Guillaume Baudry, Maja Cikes, Stamatis Adamopoulos, Tuvia Ben-Gal, Nicolas Girerd, Andreas Zuckermann, Marco Masetti, Sanem Nalbantgil, Laurens Tops, Piotr Ponikowski und 4 weitere

European Journal of Heart Failure · 01.06.2025 · 27 (6) · 1089-1102

DOI: 10.1002/ejhf.3681 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Heart Failure, online erschienen am 07.05.2025. Verfasst von Hoong Sern Lim und 15 weiteren Autor:innen. Beteiligte Einrichtung: University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Hauptthemen laut MEDLINE: Heart Transplantation, Heart Failure, Tissue and Organ Procurement, Tissue Donors. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart transplantation remains the gold standard for treatment of most patients with advanced heart failure (HF), but despite improvements of organ recovery and utilization, donor heart scarcity remains a critically limiting factor. Detailed heart allocation systems (HASs) are in place to ensure use of organs for appropriate candidates, In Europe multiple, different HASs have evolved in different countries or communities of collaborating countries, like Eurotransplant or Scandiatransplant. In this scientific statement, we review the generic ethical and practical principles underlying allocation principles and examine and describe different European HASs with the purpose of discussing impact of outcomes for patients with advanced HF. It is shown that European HASs differ significantly with respect to which patients are prioritized and the methods by which the prioritization is performed. It is argued that the most commonly used parameter to describe success of a HAS, namely 1-year survival after heart transplantation, is a poor metric of HAS performance. The impact of HASs should be evaluated by several measures such as survival from listing, time to transplantation, the characteristics of patients undergoing heart transplantation, and over a longer time interval to understand the balance of early and late post-transplant risks and benefit. Mapping European HASs is a step towards understanding these factors and further research should determine the optimal HAS in a given HF population at a given time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationHeart FailureTissue and Organ ProcurementTissue DonorsResource AllocationHumansEuropeSocieties, MedicalWaiting Lists

Stichwörter der Autor:innen

Donor organsHeart transplantationTransplant survival

Autor:innen und Institutionen

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
  • University of Groningen, Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique, INSERM 1433, CHRU de Nancy, Institut Lorrain du Coeur et des Vaisseaux, INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Ne…
  • REICATRA, Université de Lorraine, Metz, France.
  • University of Zagreb School of Medicine, Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.

Zitieren

APA

Lim, H. S., Damman, K., Baudry, G., Cikes, M., Adamopoulos, S., Ben-Gal, T., Girerd, N., Zuckermann, A., Masetti, M., Nalbantgil, S., Tops, L., Ponikowski, P., Crespo-Leiro, M., Ruschitzka, F., Metra, M., & Gustafsson, F. (2025). Donor Heart Allocation Systems in Europe A Scientific Statement of the Heart Failure Association of the ESC. European Journal of Heart Failure, 27(6), 1089-1102. https://doi.org/10.1002/ejhf.3681

Vancouver

Lim HS, Damman K, Baudry G, Cikes M, Adamopoulos S, Ben-Gal T, et al. Donor Heart Allocation Systems in Europe A Scientific Statement of the Heart Failure Association of the ESC. European Journal of Heart Failure. 2025;27(6):1089-1102. doi:10.1002/ejhf.3681

BibTeX
@article{Lim2025,
  author = {Lim, Hoong Sern and Damman, Kevin and Baudry, Guillaume and Cikes, Maja and Adamopoulos, Stamatis and Ben-Gal, Tuvia and Girerd, Nicolas and Zuckermann, Andreas and Masetti, Marco and Nalbantgil, Sanem and Tops, Laurens and Ponikowski, Piotr and Crespo-Leiro, Maria and Ruschitzka, Frank and Metra, Marco and Gustafsson, Finn},
  title = {Donor Heart Allocation Systems in Europe A Scientific Statement of the Heart Failure Association of the ESC},
  journal = {European Journal of Heart Failure},
  year = {2025},
  volume = {27},
  number = {6},
  pages = {1089--1102},
  doi = {10.1002/ejhf.3681}
}
Kostenlos starten →